LUGANO and GLATTBRUGG, Switzerland, May 16, 2013 /PRNewswire/ -Helsinn Healthcare SA and Vifor Pharma, announced that the companies have entered into an exclusive license and distribution agreement for netupitant-palonosetron fixed dose combination, …
